Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter Study Investigating Reherniation Risk Factors and Associated Costs in Primary Lumbar Disc Herniation Patients

NCT02477176 is registered in ClinicalTrials.gov with Intrinsic Therapeutics as lead sponsor.

NCT NCT02477176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02477176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter Study Investigating Reherniation Risk Factors and Associated Costs in Primary Lumbar Disc Herniation Patients
Lead sponsor
Intrinsic Therapeutics
Phase
Observational
Overall status
Unknown status
Start date
February 17, 2016
Completion date
March 31, 2025
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar spine disc herniation